Domestic biosimilar-related stocks are showing broad strength from the early hours of trading on the first trading day of October.

As of 10:38 a.m. on the 1st, Samchundang Pharmaceutical is trading at 198,300 won, up 14.76% from the previous trading day. It is the most notable mover among related stocks, posting a double-digit gain.

Following it, Samsung Epis Holdings is trading at 376,000 won, up 8.67%; Hanall BioPharma is up 7.37% at 47,350 won; and Green Cross is up 4.55% at 128,600 won.

Alteogen is up 3.54% at 263,500 won, Hanmi Pharmaceutical is up 3.41% at 516,000 won, and Celltrion is up 3.21% at 183,400 won. Daewoong Pharmaceutical (+2.73%), Bynax (+2.73%), Celltrion Pharm (+2.62%), and ISU Abxis (+2.35%) are also all continuing their gains.

As biosimilar-related stocks rise today, buying interest is flowing into the sector as a whole. Attention is focused on whether major bio stocks, including Samchundang Pharmaceutical and Alteogen, can maintain their intraday gains.

[※ This article is for investment reference purposes only and does not constitute a recommendation to invest in any specific stock. All investments are made at the individual's own discretion, and the final responsibility for buying and selling rests with the investor.]